Eric T Matey
Overview
Explore the profile of Eric T Matey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varma R, Staab J, Matey E, Wright J, Deb B, Lazaridis K, et al.
Neurogastroenterol Motil
. 2023 Dec;
36(2):e14722.
PMID: 38072827
Background: How variations predicted by pharmacogenomic testing to alter drug metabolism and therapeutic response affect outcomes for patients with disorders of gut- brain interaction is unclear. Aims: To assess the...
2.
Wang L, Scherer S, Bielinski S, Muzny D, Jones L, Black 3rd J, et al.
Genet Med
. 2022 Mar;
24(5):1062-1072.
PMID: 35331649
Purpose: The Mayo-Baylor RIGHT 10K Study enabled preemptive, sequence-based pharmacogenomics (PGx)-driven drug prescribing practices in routine clinical care within a large cohort. We also generated the tools and resources necessary...
3.
Wright J, Moyer A, Sutton J, Chaney A, Nicholson W, El Melik R, et al.
Pharmacogenomics
. 2021 Nov;
22(18):1177-1183.
PMID: 34747639
Pharmacogenomics (PGx) tests are performed on whole-blood or saliva specimens. In patients with a transplanted liver, PGx results may be discordant with hepatic drug metabolizing enzyme activity. We evaluate the...
4.
Matey E, Ragan A, Oyen L, Vitek C, Aoudia S, Ragab A, et al.
Pharmacogenomics J
. 2021 Oct;
22(1):69-74.
PMID: 34671112
Purpose: The Pharmacogenomics (PGx) Profile Service was a proof-of-concept project to implement PGx in patient care at Mayo Clinic. Methods: Eighty-two healthy individuals aged 18 and older underwent genotyping of...
5.
Bishop J, Huang R, Brown J, Mroz P, Johnson S, Allen J, et al.
Pharmacogenomics
. 2021 Jun;
22(11):681-691.
PMID: 34137665
Several healthcare organizations across Minnesota have developed formal pharmacogenomic (PGx) clinical programs to increase drug safety and effectiveness. Healthcare professional and student education is strong and there are multiple opportunities...
6.
Nicholson W, Formea C, Matey E, Wright J, Giri J, Moyer A
Mayo Clin Proc
. 2020 Dec;
96(1):218-230.
PMID: 33308868
Many practitioners who have not had pharmacogenomic education are required to apply pharmacogenomics to their practices. Although many aspects of pharmacogenomics are similar to traditional concepts of drug-drug interactions, there...
7.
Moyer A, Matey E, Miller V
Pharmacol Res Perspect
. 2019 Dec;
7(6):e00541.
PMID: 31844524
Clinically relevant adverse drug reactions differ between men and women. The underlying physiological and pharmacological processes contributing to these differences are infrequently studied or reported. As gene expression, cellular regulatory...
8.
Bielinski S, St Sauver J, Olson J, Larson N, Black J, Scherer S, et al.
Int J Epidemiol
. 2019 Aug;
49(1):23-24k.
PMID: 31378813
No abstract available.
9.
Formea C, Nicholson W, Vitek C, Wix K, McCullough K, Cunningham J, et al.
Am J Health Syst Pharm
. 2018 Oct;
75(23):1939-1946.
PMID: 30301720
Purpose: The development, implementation, and evaluation of a pharmacogenomics education program for pharmacists in a large, integrated multicampus health system are described. Summary: Pharmacogenomics has been described as tailoring medications...
10.
Cousin M, Matey E, Blackburn P, Boczek N, McAllister T, Kruisselbrink T, et al.
Mol Genet Genomic Med
. 2017 May;
5(3):269-279.
PMID: 28546997
Background: We characterized the pharmacogenomics (PGx) results received by diagnostic odyssey patients as secondary findings during clinical whole exome sequencing (WES) testing as a part of their care in Mayo...